Cervical Cancer Recurrent

Explore clinical trials studying Cervical Cancer Recurrent. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Cervical Cancer Recurrent trial results

Recruiting

HPV After chemoRadioTherapy

NCT07493928

Conditions: Cell Free DNA, Cervical Cancer Recurrent, Female Urogenital Diseases, +14 more
Locations: General Faculty Hospital in Prague Prague, Czechia

View Trial Details

Recruiting

A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB

NCT06781151

Conditions: Adnexal Diseases, Cervical Cancer Recurrent, Endocrine Gland Neoplasms, +20 more
Locations: Sun Yat'sen University Cancer Center Guangzhou, Guangdong, China

Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center Shenzhen, Guangdong, China

View Trial Details

Recruiting

RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer

NCT06063018

Conditions: Cervical Cancer Recurrent
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

NCT07266350

Conditions: Cervical Cancer Metastatic, Cervical Cancer Recurrent
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer

NCT07143292

Conditions: Cervical Cancer Metastatic, Cervical Cancer Recurrent
Locations: Not specified

View Trial Details

Not Yet Recruiting

QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

NCT07141186

Conditions: Cervical Adenocarcinoma, Cervical Cancer, Cervical Cancer Metastatic, +15 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

NCT03614949

Conditions: Cervical Cancer, Cervical Cancer Metastatic, Cervical Cancer Recurrent, +13 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Ohio State University - OSUMC - Wexner Medical Center Hilliard, Ohio, United States

View Trial Details

Cervical Cancer Recurrent

Cervical Cancer Recurrent trial results

HPV After chemoRadioTherapy

A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB

RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer

A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer

A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer

QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Related conditions